Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Masimo
MedTech
Danaher buys patient monitoring specialist Masimo in $9.9B deal
Danaher Corp. is snapping up patient monitoring medtech Masimo in a $9.9 billion deal aimed at strengthening its diagnostics portfolio.
Natalie Missakian
Feb 18, 2026 3:05am
Masimo nets $634M verdict vs Apple; US again weighs import ban
Nov 17, 2025 11:17am
FDA warns against unreviewed blood pressure tech, baby monitors
Sep 17, 2025 12:00pm
Philips, Masimo re-up patient monitor partnership with AI focus
Sep 12, 2025 12:00pm
Masimo sues US Customs over Apple Watch pulse ox green light
Aug 21, 2025 11:15am
Apple Watch gets blood oxygen tracking back with software update
Aug 14, 2025 11:30am
